The new study, which shows that treatment with a molecular decoy may lessen recurrent infections, was a collaboration with Jeffrey Gordon, MD.
The new study, which shows that treatment with a molecular decoy may lessen recurrent infections, was a collaboration with Jeffrey Gordon, MD.